US Patent 8999331 Immunobinders directed against sclerostin
Patent 8999331 was granted and assigned to AbbVie Inc. on April, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8999331 Immunobinders directed against sclerostin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.